BridgeMD
New treatment option for Virus-HIV
Official title Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
ClinicalTrials.gov ID: NCT07388394
What this study is testing
- What it's testing
- Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 and older
You may be able to join if
- HIV-positive
- Aged 75 or over
- Affiliated with the social security system
- Having expressed no objection to participating in the study
You likely can't join if
- Refusal to participate
- Known severe cognitive impairment preventing the interview from being conducted
- Patient under guardianship or conservatorship
The study team makes the final eligibility decision.
Where it's taking place
- Nice, CHU de Nice, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, CHU de Nice, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.